John F Sheridan Tandem Diabetes Care Inc (TNDM) insider trading activity

John F Sheridan is PRESIDENT & CEO of TANDEM DIABETES CARE INC. Currently has a direct ownership of 79,009 shares of TNDM, which is worth approximately $1.72 Million. The most recent transaction as insider was on Feb 25, 2025, when has been sold 13,427 shares (Common Stock) at a price of $33.34 per share, resulting in proceeds of $447,656. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79K

46.43% 3M change

164.35% 12M change

Total Value Held $1.72 Million

John F Sheridan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 25 2025	SELL Payment of exercise price or tax liability	$447,656 $33.34 p/Share	13,427 Reduced 14.53%	79,009 Common Stock
Feb 25 2025	BUY Exercise of conversion of derivative security	-	32,779 Added 26.91%	89,017 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$106,501 $33.47 p/Share	3,182 Reduced 5.06%	59,657 Common Stock
Feb 18 2025	BUY Exercise of conversion of derivative security	-	8,502 Added 12.1%	61,754 Common Stock
Nov 15 2024	SELL Payment of exercise price or tax liability	$117,808 $27.34 p/Share	4,309 Reduced 7.4%	53,956 Common Stock
Nov 15 2024	BUY Grant, award, or other acquisition	$5,958 $15.64 p/Share	381 Added 0.7%	54,337 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	-	8,499 Added 13.03%	56,729 Common Stock
Aug 15 2024	SELL Payment of exercise price or tax liability	$188,864 $43.82 p/Share	4,310 Reduced 7.97%	49,766 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	-	8,501 Added 13.93%	52,540 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$21,519 $51.73 p/Share	416 Reduced 0.9%	45,575 Common Stock
May 28 2024	BUY Exercise of conversion of derivative security	-	820 Added 1.75%	45,991 Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$502,595 $47.37 p/Share	10,610 Reduced 19.02%	45,171 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	24,915 Added 31.47%	54,245 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	$15,295 $15.64 p/Share	978 Added 3.07%	30,866 Common Stock
Feb 27 2024	SELL Payment of exercise price or tax liability	$8,010 $27.34 p/Share	293 Reduced 0.97%	29,888 Common Stock
Feb 27 2024	BUY Exercise of conversion of derivative security	-	819 Added 2.64%	30,181 Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$30,168 $24.29 p/Share	1,242 Reduced 4.06%	29,362 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	-	3,029 Added 9.09%	30,279 Common Stock
Nov 27 2023	SELL Payment of exercise price or tax liability	$5,529 $19.47 p/Share	284 Reduced 1.02%	27,575 Common Stock
Nov 27 2023	BUY Exercise of conversion of derivative security	-	820 Added 2.86%	27,859 Common Stock
Nov 15 2023	SELL Payment of exercise price or tax liability	$19,073 $18.2 p/Share	1,048 Reduced 3.73%	27,039 Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	-	3,028 Added 9.82%	27,813 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	$1,516 $15.47 p/Share	98 Added 0.39%	25,059 Common Stock
Aug 28 2023	SELL Payment of exercise price or tax liability	$7,685 $27.06 p/Share	284 Reduced 1.12%	24,961 Common Stock
Aug 28 2023	BUY Exercise of conversion of derivative security	-	820 Added 3.15%	25,245 Common Stock

Also insider at

AFIB

Acutus Medical, Inc. Healthcare

Director

JFS

John F Sheridan

PRESIDENT & CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNDM shares.

Notify only if

Value

Insider Trading

Get notified when an Tandem Diabetes Care Inc insider buys or sells TNDM shares.

Notify only if

Operation

Value

Type

News

Receive news related to TANDEM DIABETES CARE INC

Track Activities on TNDM

Account